Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma

Withdrawn before enrolling · Phase 3

Conditions studied: Acquired Bleeding Disorder, Trauma

In brief

This trial is conducted in the United States of America (USA). The purpose of this study is to evaluate the treatment of Recombinant Faction VIIa in Patients with Severe Bleeding Due to Trauma Please note that this trial and trial F7TRAUMA-1711 (NCT00184548) have been merged.

Key facts

Study ID

NCT00323570

Run by

Novo Nordisk A/S

People needed

0

Starts

2006-05-01

Expected to finish

2007-06-01

Last updated by the study team

2012-06-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Trauma injury (blunt and/or penetrating) with evidence of active torso hemorrhage refectory to standard treatment

Where it is running

• Novo Nordisk Clinical Trial Call Center — Phoenix, Arizona, United States
• Novo Nordisk Clinical Trial Call Center — Los Angeles, California, United States
• Novo Nordisk Clinical Trial Call Center — Sacramento, California, United States
• Novo Nordisk Clinical Trial Call Center — Colorado Springs, Colorado, United States
• Novo Nordisk Clinical Trial Call Center — Washington D.C., District of Columbia, United States
• Novo Nordisk Clinical Trial Call Center — Gainesville, Florida, United States
• Novo Nordisk Clinical Trial Call Center — Jacksonville, Florida, United States
• Novo Nordisk Clinical Trial Call Center — Miami, Florida, United States
• Novo Nordisk Clinical Trial Call Center — Chicago, Illinois, United States
• Novo Nordisk Clinical Trial Call Center — Maywood, Illinois, United States
• Novo Nordisk Clinical Trial Call Center — Indianapolis, Indiana, United States
• Novo Nordisk Clinical Trial Call Center — Louisville, Kentucky, United States
• Novo Nordisk Clinical Trial Call Center — Portland, Maine, United States
• Novo Nordisk Clinical Trial Call Center — Baltimore, Maryland, United States
• Novo Nordisk Clinical Trial Call Center — Boston, Massachusetts, United States
• Novo Nordisk Clinical Trial Call Center — Detroit, Michigan, United States
• Novo Nordisk Clinical Trial Call Center — Springfield, Missouri, United States
• Novo Nordisk Clinical Trial Call Center — St Louis, Missouri, United States
• Novo Nordisk Clinical Trial Call Center — Las Vegas, Nevada, United States
• Novo Nordisk Clinical Trial Call Center — Camden, New Jersey, United States
• Novo Nordisk Clinical Trial Call Center — Brooklyn, New York, United States
• Novo Nordisk Clinical Trial Call Center — The Bronx, New York, United States
• Novo Nordisk Clinical Trial Call Center — Greenville, North Carolina, United States
• Novo Nordisk Clinical Trial Call Center — Winston-Salem, North Carolina, United States
• Novo Nordisk Clinical Trial Call Center — Akron, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.